Search
Now showing items 1-10 of 86
The apolipoprotein C-I content of very-low-density lipoproteins is associated with fasting triglycerides, postprandial lipemia, and carotid atherosclerosis
(Journal article; Tidsskriftartikkel; Peer reviewed, 2011)
Experimental studies in animals suggest that apolipoprotein (apo) C-I is an important regulator of triglycerides in fasting and postprandial conditions and associated with carotid atherosclerosis. Methods. A cross-sectional study was conducted with 81 subjects, aged 56–80 years recruited from a population health survey. The participants underwent a fat tolerance test (1 g fat per Kg body weight) and ...
High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2011)
High-sensitivity C-reactive protein is associated with risk of arterial cardiovascular disease but
conflicting results have been reported on its role in venous thromboembolic disease. The objective of our study was to investigate the association between high-sensitivity C-reactive protein levels and risk of future venous thromboembolism in a prospective cohort recruited from a general population. ...
Family History of Myocardial Infarction and Cause-Specific Risk of Myocardial Infarction and Venous Thromboembolism - The Tromsø Study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014)
Obesity measures and risk of venous thromboembolism and myocardial infarction
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014)
Venous thromboembolism increases the risk of atrial fibrillation: The tromsø study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014)
N-Acetyl-β-D-Glucosaminidase Does Not Enhance Prediction of Cardiovascular or All-Cause Mortality by Albuminuria in a Low-Risk Population
(Journal article; Tidsskriftartikkel; Peer reviewed, 2015-06-05)
Albuminuria is a well known risk factor for cardiovascular disease and mortality, but focus on renal tubular dysfunction as a potential risk factor is growing also. The association between the urinary activity of N-acetyl-β-D-glucosaminidase (NAG) and cardiovascular risk has been assessed mostly in cross-sectional studies. We studied the cross-sectional associations between urinary NAG and cardiovascular ...
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants
(Journal article; Tidsskriftartikkel; Peer reviewed, 2016-11-15)
Background:<br>Raised blood pressure is an important risk factor for cardiovascular diseases and chronic kidney disease.
We estimated worldwide trends in mean systolic and mean diastolic blood pressure, and the prevalence of, and
number of people with, raised blood pressure, defi ned as systolic blood pressure of 140 mm Hg or higher or diastolic
blood pressure of 90 mm Hg or higher.<br>
Methods:<br>For ...
Association between diastolic dysfunction and future atrial fibrillation in the Tromsø Study from 1994 to 2010
(Journal article; Tidsskriftartikkel; Peer reviewed, 2015-05-13)
Objective. To investigate the association between echocardiographic measurements with emphasis on diastolic dysfunction and risk of atrial fibrillation (AF) in a population-based cohort study.
Methods. We followed 2406 participants from the Tromsø Study from 1994 to 2010. Left atrial (LA) size and mitral Doppler indices as measured by echocardiography were used for evaluating diastolic dysfunction. ...
Race/ethnic differences in the associations of the Framingham risk factors with carotid IMT and cardiovascular events
(Journal article; Tidsskriftartikkel; Peer reviewed, 2015-07-02)
Background
Clinical manifestations and outcomes of atherosclerotic disease differ between ethnic
groups. In addition, the prevalence of risk factors is substantially different. Primary prevention
programs are based on data derived from almost exclusively White people. We investigated
how race/ethnic differences modify the associations of established risk factors with
atherosclerosis and ...
Long-Term Use of Lipid-Lowering Drugs Slows Progression of Carotid Atherosclerosis The Tromso Study 1994 to 2008
(Journal article; Tidsskriftartikkel; Peer reviewed, 2013)
Data on the effect of lipid-lowering drugs (LLD) on carotid atherosclerosis outside clinical trials are limited. The aim of this study was to determine the effect of LLD on change in carotid intima media thickness and total plaque area in a general population.
Subjects were 1532 women and 1442 men who participated in a longitudinal population-based study with ultrasound examination of intima media ...